AI-generated summary
The authors report a pilot study of seven children and adolescents with orofacial pain treated with dual-wavelength photobiomodulation over four weeks, measuring pain, temperature and light transmission. They describe lower pain values over time and measured light reaching the buccal mucosa. Because the design was uncontrolled and exploratory, the authors state the findings should not be taken as evidence of clinical efficacy or causality.
- Participants
- 7
- Who or what was studied
- Children and adolescents aged six to 17 years with orofacial pain
- Wavelengths
- 810, 980 nm
- Limits stated in the abstract
- The study was uncontrolled, involved only seven participants, and its exploratory correlations had wide confidence intervals, so efficacy and causality cannot be inferred.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on link.springer.com.
Record from PubMed, a service of the National Library of Medicine.
Light parameters mentioned
Found in the title and abstract by pattern. They may be incomplete, so check the paper before comparing studies.
- Wavelength
- 810 nm, 980 nm
- Power
- 0.3 W, 0.10 mW
- Total energy
- 3.9 J
How to read a single study: what to check before relying on this kind of research.
Terms in this paper: Photobiomodulation, Pilot study, Wavelength, Irradiance, Laser. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.